BMC Clinical Pharmacology

Table 9 Contents of the commercial samples

From: Comparative in vitrostudy of the antimicrobial activities of different commercial antibiotic products for intravenous administration

Samples	Piperacillin/Tazobactam		Meropenem
	Group 1	Group 2	Group 1	Group 2
1	103.9	103.6	100.85	107.5
2	99.0	115.8	94.9	109.5
3	116.0	109.7	93.52	105.3
4	110.8	109.4	94.30	116.9
5	119.2	108.7	91.92	104.5
6	1156	105.3	97.75	105.9
7	110.6	110.5	94.02	107.2
8	113.9	111.3	94.64	115.7
9	114.7	104.2	90.76	107.2
10	116.2	107.9	92.89	103.3
11	111.2	116.8	93.32	105.7
12	112.4	117.6	95.28	107.1
13	114.6	114.3	95.29	102.5
14	116.2	108.9	92.86	103.4
15	108.2	110.1	93.43	106.2
16	114.1	108.5	93.84	104.5
17	117.9	112.6	94.22	105.1
18	110.3	104.9	97.32	106.7
19	114.8			105.8
20	111.9			107.1
21	109.9

Back to article page